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A b s t r a c t  
Poly lactic acid-co-poly ethylene glycol-co-Poly lactic acid (PLA-PEG-PLA) co-polymer was 
synthesized and after determination of its biological properties was used for intracellular delivery of 
poor soluble peptide drug, gramicidin. Toxicity of this polymer on LNCaP cell line was determined by 
MTT assay. Treatment of cells with fluorescein isothiocyanate (FITC) loaded nanoparticles and 
fluorescence microscopy indicates ability of this carrier for intracellular delivery. PLA-PEG-PLA 
nanoparticles containing poor soluble peptide drug, gramicidin, was prepared by solvent evaporation 
method. In order to confirm loading of gramicidin on PLA-PEG-PLA nanoparticles, FT-IR, 
spectrofluoremeteric, circular dichroism (CD), and scanning electron microscopy (SEM) studies 
were carried out. Our studies revealed treatment of prostate cancer cell line, LNCaP, with gramicidin 
loaded nanoparticles was more effective than gramicidin alone in killing cancer cells. 
Keywords: PLA-PEG-PLA block co-polymer, hemolytic activity, biocompatibility, FITC, gramicidin, 
nanoparticle     
 
 
Introduction 
Recombinant DNA technology developments led to availability of 
many protein and peptide drugs and some of these agents can 
cause cancerous cells death [1] but, physicochemical properties of 
protein and peptide drugs such as molecular weight, solubility and 
stability differ from conventional drugs and restrict clinical use of 
them [2, 3]. Hydrophobic drugs have poor bioavailability and can 
precipitate in blood vessels which result in undesired side effects 
[4, 5]. Susceptibility of biomacromolecule drugs to enzymes which 
are present in the body, recognition of them as antigens and 
remove of them by reticulo-endothelial system and kidney influence 
bioavailability of drugs. Cell membrane Impermeability is another 
obstacle for use of protein and peptide drugs which have 
intracellular targets. At the other hand many drugs can act on 
normal and target cells which result in undesired side effects [2, 6]. 
In order to overcome limitations related to use of biomacromolecule 
drugs and to maximize therapeutic potential and minimize side 
effects use of polymeric nanocarriers as drug delivery systems is 
beneficial. Encapsulation of hydrophobic drugs in the core of 
micellar nanoparticles formed through the self-assembly of block 
copolymers in solution not only increase apparent water solubility 
of drugs [7] but also protect them from premature degradation and 
contact with biological environment before arriving to disease site. 
Furthermore, use of nanoparticles cause accumulation of drugs 
through passive targeting and EPR effect [8, 9]. 
Polyethylene glycol (PEG) modified nanoparticles are most popular 
stealth nanoparticles and can evade the recognition by 
reticuloendothelial system [10]. Nanoparticles prepared from 
polyethylene glycol-modified poly lactic acid (PEG-PLA) have good 
biodegradability and biocompatibility and are in phase II of clinical 
trials as carriers for paclitaxel [11]. 
 In this study, PLA-PEG-PLA was synthesized and after 
determining biocompatibility of these polymeric nanoparticles on 
cancerous cell line, LNCaP, they were applied as carrier for a 
hydrophobic peptide, gramicidin, as drug. Gramicidin loaded 
nanoparticles were prepared by solvent evaporation method and 
cytotoxicity of gramicidin in loaded on nanoparticles and free 
manner was evaluated by MTT assay.  
Materials and methods 
Materials 
L-lactic acid, toluene, ethanol, ethyl acetate, antimony trioxide 
(Sb2O3), dichloromethane (DCM), polyethylene glycol (PEG Mn = 
2000), 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide 
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(MTT), dimethyl sulfoxide (DMSO), glutaraldehyde, acetone, 
CuCL2, NaCl, KCl, KH2PO4, Na2HPO4, HCl, MgCl2, NaOH, 
NaHCO3 were purchased from Merck. Stannous octoate was 
purchased from Sigma-Aldrich. anilino naphthalene sulfonate 
(ANS), fluorescein isothiocyanate (FITC) and gramicidin were 
obtained from sigma and cell culture media RPMI1640, fetal bovine 
serum (FBS) and trypsin-EDTA from GIBCO, Invitrogen Corp 
(USA). Formaldehyde was purchased from Dr.mojallali chemical 
laboratories,(iran) and prostate cancer cell line, LNCaP, from 
Pasteur institute and PLA-PEG-PLA synthesized in our lab. 
Biological properties  
Cell culture and cytotoxicity 
In order to polymer toxicity determination MTT assay was 
performed. Prostate cancer cell line LNCaP was grown under 
standard cell culture conditions in RPMI 1640 supplemented with 
10% FBS and 1% penicillin/streptomycin. Seeded cells in 24 well 
plates were maintained in incubator (5% co2, 37°C and humidified 
atmosphere) for 24 h to reach 70-80% confluency. MTT assay was 
performed as reported [12]. Growth medium was replaced with new 
ones and nanoparticles were added at different concentrations. 
Plates were returned to incubator and after desired times of 
incubation 50µl MTT solution (5mg in 1ml PBS) was added to 
culture medium and incubated for further 3h. Then growth medium 
containing MTT was replaced with 1ml DMSO to dissolve formazan 
crystals and its absorption was determined in 570 nm. All 
experiments were set up in triplicates and relative growth inhibition 
compared to control cells was measured.         
Fluorescence microscopy and up take by cells 
Ability of polymeric nanoparticles in entrance to cells was 
examined by incorporating fluorescein isothiocyanate (FITC) into 
polymeric micelles. FITC loaded nanoparticles was prepared by 
direct dissolution method [13]. Briefly, FITC with appropriate 
amount of polymer dissolved in PBS and after sonication for 30 min 
the solution remained for further 30min at room temperature. 
Unloaded FITC was removed by centrifugation and washing two 
times in PBS. Cells were treated with FITC loaded nanoparticles 
for 2h and washed in PBS, fixed for 10min (2% formaldehyde/0.2% 
glutaraldehyde in PBS) and used for fluorescence microscopy. 
Loading studies 
FT-IR, Fluorescence, CD and SEM studies for Gramicidin loaded 
nanoparticle 
FT-IR, Fluorescence, CD and SEM studies were performed to 
confirm loading of gramicidin on nanoparticles. Also loading 
efficiency and location of gramicidin on nanoparticles were studied 
by fluorescence spectroscopy. Gramicidin loaded nanoparticles 
were prepared using solvent evaporation method. Briefly 20µg 
gramicidin dissolved in 10 µl acetone and different concentrations 
(1, 2, 3, 4, 5, 6 mg/ml) of polymer (stock: 166.6 mg in 1ml PBS) 
were added, Sonicated for 30 min (bath sonicator), in order to 
micelle formation and acetone elimination the prepared solution 
was kept at room temperature for further 30 min. for FT-IR studies 
this loaded nanoparticles (ratio of polymer/peptide: 4mg/20 µg)  
were dried at 40°C under vacuum for 24 h and FT-IR spectrum 
obtained from dried loaded nanoparticles between KBr tablets with 
PerKin Elmer spectrometer. FT-IR spectrum of free gramicidin was 
recorded in crystalline form.  
Samples for fluorescence studies were prepared as above except 
that after acetone elimination to decrease turbidity resulted from 
unloaded poor soluble peptide drug, gramicidin, 30 µl ethanol was 
added to samples and final volume of 0.5 ml for samples obtained 
by adding PBS. Also utilized concentrations of polymer were: 3, 5 
and 6 mg/ml.  The Cu2+ ions block the fluorescence of any dye 
molecules available in the aqueous solution, and hence any dye 
not encapsulated completely in the core is effectively removed from 
the fluorescence measurement [7]. To demonstrate gramicidin was 
contained completely within the core of micelles same amount of 
CuCl2 (dissolved in PBS) was added for same time to each 
sample. Measurements were made by exciting tryptophan residues 
at 292 nm and emitted light detected from 300-500 nm (Cary 
Eclipse, Australia). Slit number for excitation and emission 
wavelength was 5 nm.    
CD studies also carried out to demonstrate loading of gramicidin on 
polymeric nanoparticles. 50µg gramicidin dissolved in 25 µl 
acetone and formulated with 2.5 mg polymer as samples for 
fluorescence studies (except that no CuCl2 was added). All CD 
measurements were obtained employing an Aviv 215 (Aviv 
Instrument, Inc., Lake Wood, NJ, USA) spectropolarimeter. 
Size and shape of gramicidin loaded nanoparticles were 
determined by SEM. For these aim a thin film of gramicidin loaded 
nanoparticles and gramicidin alone (were prepared as FT-IR 
sample) on glass (ratio of polymer/peptide: 4mg/20 µg) were 
applied.Cytotoxicity of free gramicidin and gramicidin loaded 
nanoparticles 
In order to determine the neat effect of gramicidin on cells 
treatments were classified into two groups. The first one (40ga-pol) 
was included 40 µg/ml of gramicidin alone and different 
concentrations of polymer (1, 2, 3, 4 & 5 mg/ml) which were 
formulated with constant concentration of gramicidin, 40 µg/ml and 
the second group (pol) consists of different concentrations of 
polymer alone (1, 2, 3, 4 & 5 mg/ml). Formulation was performed 
as SEM and FT-IR samples and after 30 min remaining at room 
temperature were used for cell treatment. Untreated cells 
considered as negative control. 
Results 
Biological properties 
Cytotoxicity of polymeric nanoparticles on cancerous cell line, 
LNCaP.  
MTT assay was don for five different concentrations of polymeric 
Nano carriers (1, 2.5, 5, 10 and 15 mg/ml) at different treatment 
times (16, 24 and 48 hours). Untreated cells considered as 
negative control and viability calculated against them. As shown in 
Fig.1 significant cytotoxicity for 16 and 24 h treatments was 
appeared at concentrations above 5 mg/ml but for 48 h treatment 
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viability reduced to %91.98 at this concentration (5 mg/ml). Cell 
treatment with 10 and 15 mg/ml of this nanoparticles show 
significant reduced viability for all treatment times. Calculated IC50 
for treated cells at 16, 24 and 48 hours is 14.71, 9.256 and 7.8 
mg/ml respectively. These data indicated that the prepared 
nanoparticles at concentrations below 5 mg/ml are non-toxic to 
LNCaP cells and cause cell death in a time and concentration 
dependent manner. 
Fluorescence microscopy and up take by cells 
In one of the earlier investigation it was shown that following 
uptake of FITC-containing nanoparticles by tumor cells if 
nanoparticles lose their structural integrity and release the FITC 
into the cytosol fluorescence images of threated cells will exhibit a 
diffused fluorescence staining which is resulted from presence of 
FITC in entire intracellular matrix. Fig.2.A. represent fluorescence 
images of treated cells with FITC loaded nanoparticles. The image 
obviously reveals a diffused fluorescence staining manner which is 
related to lose of structural integrity of nanoparticles upon uptake 
by prostate cancerous cell line, LNCaP. Treated cells with polymer 
alone was considered as control (Fig.2.B).     
Loading studies 
FT-IR spectrum of gramicidin and gramicidin loaded nanoparticles  
Gramicidin A in crystalline form has β5.6 conformation. As reported 
previously FT-IR spectrum of this conformation has six 
characteristic peaks at 3285, 3078, 1638, 1542,1285 and 676 cm-1 
which are corresponded to type A, B, I, II, III and V amides 
respectively. Fourier self deconvolution (FSD) analysis was 
performed for obtained spectra of gramicidin and gramicidin loaded 
nanoparticles. Gramicidin spectrum show characteristic peaks 
which had been reported previously [14]. Spectrum of loaded 
gramicidin on nanoparticles shows a little shift in its peaks which 
confirm interactions between polymer and peptide (Table 1) (fig.3)      
Fluorescence spectra of gramicidin loaded nanoparticles 
Gramicidin has intrinsic fluorescence because of the presence of 
tryptophan residues. Loading of gramicidin in polymeric micelles 
was investigated by quenching intrinsic fluorescence of gramicidin 
in the presence of copper ions. As shown in Fig.4 fluorescence of 
tryptophan residues of gramicidin loaded nanoparticles didn’t 
quenched at the presence of copper ions because tryptophan 
residues of gramicidin were buried in the core of polymeric micelles 
so are inaccessible for quenching agent, cu2+. Increasing in 
polymer to gramicidin ratio result in more fluorescence emission 
which is related to increasing in gramicidin loading and this 
continue until gramicidin loaded completely on nanoparticles and 
there isn’t free form of gramicidin.  
Far-UVCD spectra of gramicidin and, gramicidin loaded 
nanoparticles 
Far-UVCD studies have been previously used to characterize 
membrane bounded gramicidin conformations. In order to confirm 
loading of gramicidin in the core of polymeric micelles CD 
spectroscopy was utilized. As shown in Fig.5 gramicidin has two 
different spectrums in the presence and absence of polymer and 
show that interaction between polymer and peptide has occurred. 
Spectrum of gramicidin loaded nanoparticle solutions reveals 
characteristic peaks with negative elliptisity around 194 nm and 
positive elliptisity around 211 and 193 nm.  
Scanning electron microscopy for peptide loaded nanoparticles  
As shown in Fig.6.A. sonicated gramicidin forms aggregates with a 
dimensions about 200 nm and spherical to ovally forms. 
Micrograph of gramicidin loaded in the core of polymeric micelles 
exhibit that these drug containing nanoparticles have spherical 
forms with a diameter smaller than 100 nm (Fig.6.B). Smaller size 
of gramicidin containing nanoparticles not only confirms the loading 
of peptide agents also reveals that prepared carriers have a good 
size for long circulating in blood stream and passive targeting.       
Cytotoxicity of free gramicidin and gramicidin loaded nanoparticles 
Viability for all treatments was calculated against negative control. 
These results (Fig.7) indicate that gramicidin alone don’t affect 
viability of cells which is resulted from poor solubility of it but 
treated cells with gramicidin-polymer complex exhibit reduced 
viability which is consequence of loading of gramicidin in the core 
of polymeric micelles and increase in its apparent solubility. As it is 
evident from results consequence of increase in the ratio of 
polymer to peptide is improvement in the cytotoxicity effect of 
gramicidin which results from loading of more amount of gramicidin 
on nanoparticles. Zero concentration on column chart for the first 
group is corresponded to the cells which were treated with 40 
µg/ml of gramicidin alone and for the second group (pol) related to 
untreated cells and was considered as negative control.   
   
Discussion 
PLA and PEG had been shown good biocompatibility and 
biodegradability previously and have approved from the food and 
drug administration of America (FDA) [15, 16]. Previous studies 
shown that PLA is able to enter the cells and have been applied for 
intracellular delivery of drugs [17]. At the other hand stealth 
nanoparticles are very attractive for use in drug delivery. PEG is 
the most common polymer which is used for making nanoparticles 
stealth and undetectable for reticulo-endothelial system [5, 7, 18, 
19]. Furthermore polymeric micelles which are made from self-
assemble amohiphilic block copolymers are of interest for  
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Table 1. Appeared peaks in FT-IR spectra of gramicidin and gramicidin-polymer nanoparticles 
Reported frequencies for 
crystalline native ga-A (cm-1) 
Assignment  observed 
frequencies for 
ga (cm-1) 
observed frequencies 
for ga-pol (cm-1) 
    
3415 
3285 
3078 
3064 
2964 
2935 
1680 sh 
1638 
1542 
1460 
1440 sh 
1388 
1285 
1233 
1070 
676 
626 
OH stretch (ethanolamine, tyr) 
Amide A 
Amide B 
CH stretch (ring) 
CH3/CH2 stretch 
CH3/CH2 stretch 
amide I 
amide I 
amide II 
CH2 bend (side chain) 
CH2 bend (side chain) 
CH3 symmetric bend 
amide III 
amide III 
COH (ethanolamine) 
amide V 
amide V 
 
3416 
3272 
3085 
3066 
2960 
2932 
1682 
1634 
1538 
1457 
1436 
1387 
1283 
1234 
1067 
674 
− 
− 
− 
3076 
3062 
− 
2931 
1683 
1635 
1542 
1455 
− 
1385 
1275 
− 
1070 
682 
628 
ga-A = gramicidin A, ga = gramicidin, ga-pol = gramicidin polymer nanoparticles, Sh = shoulder. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Calculated viability percent for treated cells (LNCaP cell line) with different concentrations of polymeric nanoparticles 
(at 16, 24 and 48 hours). (Zero on the chart assigns untreated cells and considered as negative control). viability was 
calculated against negative control. 
 
 
 
 
 
 
 
 
 
Fig. 2. fluorescence images had been captured from treated cells with FITC loaded nanoparticles (A) and polymer alone (B) 
(control) for 2 hours. 
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Fig. 3. FT-IR spectra of gramicidin in free form (ga) and when loaded in the core of polymeric micelles (ga-pol) 
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Fig. 4. Fluorescence spectra of 40 µg gramicidin at the presence of copper ions (40ga-cu), absence of copper ions (40ga) and when 
formulated with 3 (40-3), 5 (40-5) and 6 (40-6) mg/ml of polymer at the presence of copper ions. 
 
 
 
Fig. 5. CD spectra of gramicidin in free form (100 µg/ml ga) and when loaded with 5mg/ml polymer (100 µg/ml ga-5mg/ml 
copolymer).  
 
 
 
 
Fig. 6. SEM micrographs of gramicidin aggregates (A) and gramicidin loaded nanoparticles (B) were prepared by solvent evaporation 
method. (Magnitude: 50000x. scale bar 300 nm). 
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Fig.7. Calculated viability from MTT assay results for treated cells with different concentrations (1, 2, 3, 4 and 5 mg/ml, 0 assign 
negative control) of polymer (pol) and when constant concentration of gramicidin (40 µg) was formulated with these concentrations 
of polymer (40ga-pol) (0 assign treated cells with 40 µg gramicidin alone). Viability for all treatments was calculated against 
negative control. 
 
 
 
hydrophobic drugs loading [5, 7, 19]. In this work triblock 
copolymer of biocompatible segments (PLA-PEG-PLA) was 
synthesized  
MTT assay results reveal low toxicity of prepared nanoparticles on 
cancerous cell line, LNCaP, and treatment of cells up to 5mg/ml of 
polymeric nanoparticles don’t show significant cytotoxicity. 
According obtained results from MTT assay (fig.1), we can deduce 
that these polymeric nanoparticles are applicable for drug delivery 
at in vivo conditions at concentrations up to 5mg/ml.  
Intracellular delivery of drugs through bypassing cell membrane is 
preferred because it results in resolving chemotherapy problems 
like multidrug resistances [20-22]. As shown in Fig.2 FITC loaded 
nanoparticles reveal that these polymeric micelles are able to 
deliver FITC into the cytosol.  
Gramicidin as a hydrophobic drug was loaded in the core of 
polymeric micelles and its loading was investigated by FT-IR, 
fluorescence and CD spectroscopies. FT-IR spectra of gramicidin 
in free form and when loaded in the core of polymeric micelles 
Show differences in its spectrum (table.1) (fig.3).  
The drug within micelles may locate in the corona, the core and the 
core-corona interface of the micelles. Fluorescence quenching can 
be used to evaluate amount of drug loaded completely in the 
micelle core. Bivalent cations like cu2+ are able to quench any 
fluorescent dies and are used for studying loading dye molecules in 
the core of micelles. Our results clearly show (Fig.4) that loading 
efficiency greatly affect by polymer concentration which is in 
agreement with previous studies [7] also gramicidin had been 
loaded in the core of polymeric micelles and when 40 µg/ml of 
gramicidin formulated with 6 mg/ml of polymer in the presence of 
copper ions the detected emission was equal to that detected for 
40 µg/ml of gramicidin in the absence of quencher and indicate that 
gramicidin has been loaded completely. According above 
statements we can conclude that 6.66 µg of gramicidin can load on 
1mg of copolymer. Also we can deduce that gramicidin and its 
tryptophan residues had been placed in the core of micelles 
because at this ratio of polymer to peptide in the presence of 
copper ions the emitted fluorescence is same as free gramicidin in 
the absence of quencher.Far-UVCD studies (Fig.5) also confirm 
that interaction between polymer and peptide had been occurred. 
Gramicidin when placed in the core of micelles has different 
conformation relative to gramicidin in free form and is a sign of 
interaction between polymer and peptide.Nanoparticle size has an 
important effect on efficiency of drug delivery systems. Previous 
studies report size dependence efficiency of polymeric 
nanoparticles for intracellular delivery of drugs. Increase in the size 
of nanoparticles result in decrease in cellular uptake and 
nanoparticles with a size smaller than 100 nm are more favorable 
for uptake [24]. At the other hand the optimal nanoparticles size for 
in vivo applications is generally between 10-100 nm [20, 24]. Also 
carriers with a size smaller than 100 nm are applicable for brain 
drug delivery [16, 25]. Particles with smaller than 10 nm are 
susceptible for remove by renal filtration and particles with a size 
above 100 nm are more susceptible for elimination by RES [18, 
20]. As particles are smaller their bio distributions improve and can 
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easily distribute through the tumor tissues [11]. Presence of PEG 
on the surface of nanoparticles result in long circulation time of 
nanoparticles and cause accumulation of more amount of drug in 
tumor tissue trough enhanced permeability and retention effect 
(EPR) [11, 26]. Prepared nanoparticles in this work have a 
diameter less than 100 nm (Fig.6.B) and because of the presence 
of PEG on the surface of these nanoparticles these gramicidin 
loaded nanoparticles appear to be very effective for passive 
targeting of tumors.  
Gramicidin doesn’t have significant effect on viability of cells 
because of its poor solubility. But as it loads in the core of micelles 
its apparent solubility increase and can affect viability of cells (in 
agreement with previous studies about paclitaxel [13]. MTT assay 
for gramicidin loaded nanoparticles (Fig.7) show that by increase in 
the polymer concentration (as gramicidin concentration is constant) 
effect of gramicidin on cells increase which is resulted from more 
loading of gramicidin on nanoparticles (in agreement with 
fluorescence results (Fig.4)). As previously reported increase in the 
ratio of polymer/peptide result in loading of more amount of drugs 
and at a ratio it becomes constant [7]. Reported targets for 
gramicidin are cell membrane [27], depression of aerobic and 
anaerobic glycolysis in bovine spermatozoa [28], in the case of 
gramicidin-S binding to calmodulin [29], DNA, RNA and protein 
synthesis inhibition in prokaryotic cells [30]. So it’s logical that 
presence of gramicidin in the cytosol results in interaction of it with 
intracellular targets which their normal function are more necessary 
for cell viability in compare to extracellular targets and affect 
gramicidin cytotoxicity.            
  
Conclusion    
From above statement it is concluded that these biocompatible and 
biodegradable polymeric nanoparticles are applicable for 
intracellular drug delivery at in vivo conditions and have good 
properties for passive targeting of tumor tissues. Also gramicidin 
only is used for skin injuries and eye and because of its hemolytic 
activity and poor solubility is not applicable for systemic 
administration. Loading of gramicidin on these nanoparticles 
restrict its hemolytic activity, improve its solubility and accumulation 
at disease site like tumors by EPR effect hence by this formulation 
presence of gramicidin in blood vessels is appeared possible and 
may be useful for cure of many disease like cancer. 
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